「肠系膜上动脉优先」入路与常规入路在腹腔镜胰十二指肠切除术治疗胰腺导管腺癌患者短期和长期结局中的比较研究
该回顾性研究纳入2014年6月至2021年6月连续91例接受腹腔镜胰十二指肠切除术的胰腺导管腺癌患者,比较改良肠系膜上动脉优先入路(联合后入路与前入路)与常规入路的围术期结局、病理结果和总生存期,并进行倾向性评分匹配分析。结果显示肠系膜上动脉优先组淋巴结清扫数更多,肠系膜上动脉切缘受累更低,但总生存期无显著延长。
要点
- 肠系膜上动脉优先组淋巴结清扫数多于常规组(19枚 vs 15枚,P=0.021),匹配队列中同样更多(21枚 vs 15枚,P=0.046)。
- 肠系膜上动脉优先组肠系膜上动脉切缘受累为0,常规组为13%;R0切除率两组无显著差异(93.3% vs 82.6%,P=0.197)。
- 两组中位总生存期无显著差异(肠系膜上动脉优先组21.8个月 vs 常规组19.8个月,P=0.900),匹配队列亦无差异(P=0.558)。
核心结论
- 改良肠系膜上动脉优先入路对接受腹腔镜胰十二指肠切除术的胰腺导管腺癌患者安全可行,在标本质量上有轻微优势,但总生存期未显著延长。
研究设计与样本
- 回顾性分析2014年6月至2021年6月连续91例接受腹腔镜胰十二指肠切除术的胰腺导管腺癌患者数据,分为改良肠系膜上动脉优先入路组(联合后入路与前入路)和常规入路组,比较围术期结局、病理结果和总生存期,并进行倾向性评分匹配分析。
主要发现
- 肠系膜上动脉优先组淋巴结清扫数多于常规组(19枚 vs 15枚,P=0.021),匹配队列中亦更多(21枚 vs 15枚,P=0.046)。
- R0切除率两组无显著差异(肠系膜上动脉优先组93.3% vs 常规组82.6%,P=0.197),但肠系膜上动脉切缘受累肠系膜上动脉优先组更低(0 vs 13%)。
- 两组术中出血量、手术时间、总体和主要术后并发症发生率及死亡率在原始队列和匹配队列中均无明显差异。
- 肠系膜上动脉优先组中位总生存期为21.8个月,常规组为19.8个月(P=0.900);匹配队列中生存亦无差异(P=0.558)。
- TNM分期、切除切缘、总体并发症和辅助治疗是影响总生存期的独立危险因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The use of laparoscopic pancreaticoduodenectomy (LPD) in pancreatic head cancer remains controversial, and an appropriate surgical approach can help improve perioperative safety and oncological outcomes. This study aimed to assess the short-term outcomes and long-term survival of the superior mesenteric artery first (SMA-first) approach in patients with pancreatic ductal adenocarcinoma (PDAC) undergoing LPD. METHODS: The data of 91 consecutive PDAC patients who underwent LPD from June 2014 to June 2021 were retrospectively analyzed. Patients were divided into two groups, the modified SMA-first approach group, using a combined posterior and anterior approach, and the conventional approach group. Perioperative outcomes, pathologic results, and overall survival (OS) were compared between groups, and propensity score-matched (PSM) analysis was performed. RESULTS: The number of lymph nodes harvested was greater in the SMA-first approach group (19 vs. 15, P = 0.021), as did the results in the matched cohort (21 vs. 15, P = 0.046). No significant difference was observed in the R0 resection rate (93.3% vs. 82.6%, P = 0.197), but the involvement of the SMA margin was indeed lower in the SMA-first approach group (0 vs. 13%). There were no obvious variances between the two groups in terms of intraoperative bleeding, operative time, overall and major postoperative complication rates, and mortality in either the original cohort or matched cohort. The median OS was 21.8 months in the SMA-first group, whereas it was 19.8 months in the conventional group (P = 0.900). Survival also did not differ in the matched cohort (P = 0.558). TNM stage, resection margin, overall complications, and adjuvant therapy were independent risk factors affecting OS. CONCLUSION: The modified SMA-first approach is safe and feasible for PDAC patients undergoing LPD. It had a slight advantage in specimen quality, but OS was not significantly prolonged.
引用
- Wang X, Luo Q, Li S, et al. A comparative study of the "superior mesenteric artery first" approach versus the conventional approach in short-term and long-term outcomes in patients with pancreatic ductal adenocarcinoma undergoing laparoscopic pancreaticoduodenectomy. Surg Endosc. 2023. PMID: 37891371. doi:10.1007/s00464-023-10470-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。